More Clinical Articles

Access and Evidence

Lifting the Veil: GSK Becomes the First to Share Clinical Trials Data

Zuzanna Fimińska, (Feb 6, 2013)

After months of public demands and resistance from the industry, GSK becomes the first big pharma player to back the AllTrials.net campaign – making all of their clinical trials information publically available for the first time.
Access and Evidence

Quest for Available Drug Data Continues

Zuzanna Fimińska, (Feb 5, 2013)

The on-going battle for clinical trial data continues with calls from the European Parliament for drug makers to make full results widely available.
Commercial

Patient Advocate Collaboration - Novel Methods for Rare Diseases

Louise Kelly, (Jan 29, 2013)

Louise Kelly talks to Dr. Bartholomew Tortella, Senior Director of Medical Affairs at Pfizer about rare disease clinical trials and the pivotal role patient advocacy groups can play in recruitment.
Clinical

Research Identifies Potential To Intensively Mine Bacterial Genome For New Drugs

Lucy Brake, (Jan 29, 2013)

While exploring what happens when microbes develop resistance to pharmaceuticals scientists have discovered that the process bacteria undergo when they become drug resistant can act as a powerful tool for drug discovery.
Access and Evidence

Health Committee Calling for a New Code of Practice

Zuzanna Fimińska, (Jan 22, 2013)

The Health Committee at the UK’s National Institute for Health and Clinical Excellence has urged the industry to rebuild trust with professionals and the public by making all clinical trial data available.
Access and Evidence

Merck’s Whistle Blowing Just Got Louder

Matthew Wood, (Jan 21, 2013)

After a storm of commotion in light of Merck & Co’s drug Tredaptive, which was found (when added to statins) not to reduce major vascular events as it’s supposed to, the company has taken it upon themselves to update the public on the latest developments.
Access and Evidence

Hidden Answers: the Battle to Reveal Clinical Trial Results

Louise Kelly, (Jan 18, 2013)

Currently under no legal obligation to disclose all clinical trial results, pharmaceutical companies are now being pressured by volunteers to publish full investigation findings.
Access and Evidence

Clinical Trials Worldwide Struggle to Find Participants

Ben Steele, (Jan 18, 2013)

New research has highlighted the continuing difficulty clinical trials are facing worldwide in the recruitment of participants.
Clinical

Latest Research Identifies Potential To Mass Produce New Anti-Cancer Substance

Lucy Brake, (Jan 17, 2013)

Scientists have discovered a new way to practically produce large amounts of a promising novel anti-cancer substance that kills cancer cells in a different way from existing medicines.
Access and Evidence

Pressure to Publish: A Campaign For Access to Trial Data

Zuzanna Fimińska, (Jan 14, 2013)

A public campaign, AllTrials, has been launched to influence governments, regulators and research bodies to ensure that all clinical trials, past and present, are registered and their full methods and results published.

Pages